The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2015

Filed:

Dec. 15, 2010
Applicants:

Hiroyuki Ebinuma, Ryugasaki, JP;

Kohei Takubo, Ryugasaki, JP;

Masanao Matsuo, Ryugasaki, JP;

Isamu Fukamachi, Ryugasaki, JP;

Hideaki Bujo, Chiba, JP;

Chiaki Nakaseko, Chiba, JP;

Yasushi Saito, Chiba, JP;

Inventors:

Hiroyuki Ebinuma, Ryugasaki, JP;

Kohei Takubo, Ryugasaki, JP;

Masanao Matsuo, Ryugasaki, JP;

Isamu Fukamachi, Ryugasaki, JP;

Hideaki Bujo, Chiba, JP;

Chiaki Nakaseko, Chiba, JP;

Yasushi Saito, Chiba, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 21/64 (2006.01); G01N 21/47 (2006.01); G01N 21/76 (2006.01); G01N 33/92 (2006.01);
U.S. Cl.
CPC ...
G01N 33/574 (2013.01); G01N 33/57426 (2013.01); G01N 33/92 (2013.01); G01N 2800/52 (2013.01); G01N 2800/54 (2013.01);
Abstract

To provide a method and a diagnostic kit for determining the presence of a malignant tumor or the severity thereof, a method for selecting a therapeutic method therefor or evaluating the effect of the therapeutic method, or a method for estimating the risk of recurrence of the malignant tumor or determining the presence or absence of the recurrence. The method for determining the presence of a malignant tumor or the severity thereof, method for selecting a therapeutic method therefor or evaluating the effect of the therapeutic method, or method for estimating the risk of recurrence of the malignant tumor or the presence or absence of the recurrence is characterized by including 1) a step of measuring the concentration and/or quantity of soluble LR11 in a sample originating from a subject and 2) a step of comparing the value measured above with a measurement value of soluble LR11 obtained from a healthy subject group.


Find Patent Forward Citations

Loading…